These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9447587)

  • 1. Searching for the ideal partner.
    Eckstein F
    Nat Biotechnol; 1998 Jan; 16(1):24. PubMed ID: 9447587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of the reproduction of the human immunodeficiency virus in a cell culture with antisense oligonucleotide derivatives].
    Abramova TV; Blinov VM; Vlasov VV; Gorn VV; Zarytova VF; Ivanova EM; Konevets DA; Pliasunova OA; Pokrovskiĭ AG; Sandakhchiev LS
    Dokl Akad Nauk SSSR; 1990; 312(5):1259-62. PubMed ID: 2226145
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
    Park WS; Miyano-Kurosaki N; Abe T; Takai K; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 2000 Apr; 270(3):953-60. PubMed ID: 10772932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical design of antisense RNA structures substantially improves annealing kinetics and efficacy in human cells.
    Patzel V; Sczakiel G
    Nat Biotechnol; 1998 Jan; 16(1):64-8. PubMed ID: 9447596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription.
    Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN
    Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication by foldback triple-helix forming oligonucleotides.
    Hiratou T; Tsukahara S; Takai K; Koyanagi Y; Yamamoto N; Takaku H
    Nucleic Acids Symp Ser; 1997; (37):221-2. PubMed ID: 9586079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of synthetic oligonucleotides as inhibitors of West Nile virus replication.
    Torrence PF; Gupta N; Whitney C; Morrey JD
    Antiviral Res; 2006 Jun; 70(2):60-5. PubMed ID: 16540182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mimicry of the hepatitis delta virus replication cycle mediated by synthetic circular oligodeoxynucleotides.
    Diegelman AM; Kool ET
    Chem Biol; 1999 Aug; 6(8):569-76. PubMed ID: 10421762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense that comes naturally.
    Stein CA
    Nat Biotechnol; 2001 Aug; 19(8):737-8. PubMed ID: 11479564
    [No Abstract]   [Full Text] [Related]  

  • 11. Antisense has growing pains.
    Gura T
    Science; 1995 Oct; 270(5236):575-7. PubMed ID: 7570012
    [No Abstract]   [Full Text] [Related]  

  • 12. Current concepts in antisense drug design.
    Milligan JF; Matteucci MD; Martin JC
    J Med Chem; 1993 Jul; 36(14):1923-37. PubMed ID: 8336333
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of VEGF mRNA antisense oligodeoxynucleotides by RNA structure software and their effects on HL60 and K562 cells.
    Fei J; Zhang Y
    Cell Biol Int; 2005 Sep; 29(9):737-41. PubMed ID: 15985377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.
    Henry SP; Miner RC; Drew WL; Fitchett J; York-Defalco C; Rapp LM; Levin AA
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2646-51. PubMed ID: 11581212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of antisense oligonucleotides for gene functionalization and target validation.
    Bennett CF; Cowsert LM
    Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2.
    Jiang T; Kuhen KL; Wolff K; Yin H; Bieza K; Caldwell J; Bursulaya B; Tuntland T; Zhang K; Karanewsky D; He Y
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2109-12. PubMed ID: 16464578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors.
    Daelemans D; Pannecouque C; Pavlakis GN; Tabarrini O; De Clercq E
    Mol Pharmacol; 2005 May; 67(5):1574-80. PubMed ID: 15728798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
    Korth MJ; Taylor MD; Katze MG
    Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant inhibitory effects of Hybridon's antisense compound on various HIV-1 replication steps in in vitro tests.
    AIDS Patient Care STDS; 1996 Dec; 10(6):375-6. PubMed ID: 11361558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.